ID

22739

Descrizione

Terms of use: You may not use this document or the information contained herein to a regulatory authority in connection with an application for a marketing authorization or any other regulatory submission without the express written consent of Roche Study #: FVF4170g Drug: Ranibizumab Study Title: A Phase III, Double-Masked, Multicenter, Randomized, Sham-Controlled Study Of The Efficacy And Safety Of Ranibizumab Injection In Subjects With Clinically Significant Macular Edema With Center Involvement Secondary To Diabetes Mellitus

Keywords

versioni (1)

1. 11/06/17 11/06/17 -

Titolare del copyright

Genentech, Inc.

Caricato su

11 giugno 2017

DOI

Per favore, per richiedere un accesso.

Licenza